Chitra Sharma is a Vice President of Translational Sciences, Quality and Regulatory Affairs at Scribe Therapeutics.  She has extensive expertise in drug development, global quality, and regulatory affairs.  Since joining Scribe in 2024, she has led pivotal pharmacology and toxicology programs in Translational Sciences, Global regulatory initiatives, and quality operations.

Prior to joining Scribe, Chitra founded and led gCompliance, Inc., a technical drug development consulting firm renowned for its high-quality, science-driven solutions, for 13 years.  The firm was celebrated for transforming innovative technologies into medicines that met global quality standards and regulatory approvals, consistently delivering on time with exceptional client satisfaction.

Chitra holds a Master’s degree in Pharmaceutical Sciences from the University of Connecticut and has held various roles at leading pharmaceutical companies, including Boehringer Ingelheim, Roche Biosciences, Cor Therapeutics, Genentech, and Vivus, Inc.

Outside of work, she enjoys poetry, music, dance, theater, and exploring the outdoors.